[New problems in tolerance induction].
D000818:Animals; D000906:Antibodies; D000914:Antibodies, Viral; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D000941:Antigens / Q000008:administration & dosage; D000956:Antigens, Viral; D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D001667:Binding, Competitive; D003429:Cross Reactions; D003588:Cytopathogenic Effect, Viral; D004305:Dose-Response Relationship, Drug; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology; D051379:Mice; D011135:Polysaccharides, Bacterial; D013296:Streptococcus pneumoniae / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D000914:Antibodies, Viral; D000936:Antigen-Antibody Complex; D000941:Antigens; D000956:Antigens, Viral; D011135:Polysaccharides, Bacterial
Neue Probleme der Toleranzinduktion